Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

10,273 total articles

Crown Castle Declares Quarterly Common Stock Dividend

Crown Castle Declares Quarterly Common Stock Dividend

Crown Castle Inc. declared a quarterly cash dividend of $1.0625 per common share, payable June 30, 2026, indicating confidence in its financial stability. The dividend payout reflects the company's ongoing commitment to returning value to shareholders amid its extensive U.S. cell tower operations.

California Water Service Group Promotes Tamara S. Johnson to Vice President, California Operations and Gregory D. Shimansky to Vice President, Rates and Regulatory Affairs

California Water Service Group Promotes Tamara S. Johnson to Vice President, California Operations and Gregory D. Shimansky to Vice President, Rates and Regulatory Affairs

California Water Service Group announced the promotions of Tamara S. Johnson to Vice President of California Operations and Gregory D. Shimansky to Vice President of Rates and Regulatory Affairs, effective July 1, 2026. These moves reflect the company's growth and aim to enhance operational efficiency and regulatory engagement as the company manage…

Applied Digital Reaches Significant Milestone, Surpassing 1 GW of Contracted Capacity with U.S. Based High Investment-Grade Hyperscaler Lease at Fourth Campus, Polaris Forge 3

Applied Digital Reaches Significant Milestone, Surpassing 1 GW of Contracted Capacity with U.S. Based High Investment-Grade Hyperscaler Lease at Fourth Campus, Polaris Forge 3

Applied Digital announced a major milestone by securing a 15-year, $7.5 billion take-or-pay lease agreement with a U.S.-based high investment-grade hyperscaler for its fourth AI Factory campus, Polaris Forge 3. This 300 MW critical IT load expansion brings Applied Digital's total contracted lease revenue to $31 billion, with a total contracted capa…

nCino to Participate in Upcoming Investor Event

nCino to Participate in Upcoming Investor Event

nCino, Inc., a NASDAQ-listed company providing an AI-powered banking platform, will present at the William Blair 46th Annual Growth Stock Conference, showcasing its agentic AI banking solutions to investors. The event details and the webcast replay will be accessible via nCino's Investor Relations website.

StepStone Group Reports Fourth Quarter and Fiscal Year 2026 Results

StepStone Group Reports Fourth Quarter and Fiscal Year 2026 Results

StepStone Group Inc., a global private markets investment firm, reported its fourth quarter and fiscal year 2026 results showing significant growth in assets under management (AUM) and total capital responsibility. The company declared quarterly and supplemental cash dividends, and hosted an earnings call to discuss these results. Fiscal 2026 saw a…

Financial Institutions, Inc. Announces Quarterly Cash Dividend

Financial Institutions, Inc. Announces Quarterly Cash Dividend

Financial Institutions, Inc., parent company of Five Star Bank and Courier Capital, has declared quarterly cash dividends of $0.32 per common share and dividends on its preferred stocks, payable July 2, 2026. With $6.3 billion in assets, the company offers banking and wealth management services primarily in New York and the Mid-Atlantic region.

Equillium to Host Virtual Investor Event to Share New Insights into the Aryl Hydrocarbon Receptor (AhR) and miR-124 Axis

Equillium to Host Virtual Investor Event to Share New Insights into the Aryl Hydrocarbon Receptor (AhR) and miR-124 Axis

Equillium, Inc. announced a virtual investor event to share new preclinical insights into the aryl hydrocarbon receptor (AhR) and miR-124 relationship, highlighting novel findings that could enhance understanding and therapeutic development for inflammatory diseases such as ulcerative colitis. The presentation will focus on the paradoxical effects …

Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference

Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference

Rapport Therapeutics, a clinical-stage biotechnology firm focusing on small molecule precision medicines for neurological and psychiatric disorders, announced participation in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference with scheduled fireside chats in early June 2026. The company highlights…

URBN Reports Record Q1 Sales and Income

URBN Reports Record Q1 Sales and Income

Urban Outfitters, Inc. announced record first-quarter financial results for the period ending April 30, 2026, with net sales increasing 11.4% to $1.48 billion and net income reaching a record $115.7 million. Growth was driven by increases in all major segments: Retail comparable sales rose 5.6%, subscription net sales surged 34.5%, and wholesale sa…

Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities

Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities

Longeveron Inc., a clinical-stage biotechnology company, announced a strategic repositioning focusing on capital efficiency, prioritizing licensing partnerships for its stem cell therapy laromestrocel. The company highlighted its near-term catalyst: the August 2026 data readout from its Phase 2b trial for Hypoplastic Left Heart Syndrome (HLHS), a r…

Eledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress

Eledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress

Eledon Pharmaceuticals announced it will present updated and new long-term clinical data from its Phase 2 BESTOW trial and extension study of tegoprubart, an anti-CD40L antibody, aimed at preventing kidney transplant rejection. Presentations will occur at the American Transplant Congress in June 2026, accompanied by a conference call to discuss res…

ScottsMiracle-Gro to Webcast Presentation at the William Blair 46th Annual Growth Stock Conference on June 3, 2026

ScottsMiracle-Gro to Webcast Presentation at the William Blair 46th Annual Growth Stock Conference on June 3, 2026

ScottsMiracle-Gro Company, a leading marketer of branded lawn and garden products in North America, announced that its President and COO, Nate Baxter, and CFO, Mark Scheiwer, will present at the William Blair 46th Annual Growth Stock Conference on June 3, 2026. The presentation will outline current business strategies and be available via live webc…

Star Bulk Carriers Corp. Reports Net Profit of $58.5 Million for the First Quarter of 2026, and Declares Quarterly Dividend of $0.50 Per Share

Star Bulk Carriers Corp. Reports Net Profit of $58.5 Million for the First Quarter of 2026, and Declares Quarterly Dividend of $0.50 Per Share

Star Bulk Carriers Corp., a Nasdaq-listed global dry bulk shipping company, announced robust first quarter 2026 results, including a net income of $58.5 million, significant increases in voyage revenues and EBITDA, improved daily charter rates, and a quarterly dividend of $0.50 per share. The company is executing a fleet renewal plan, delivering ne…